Liver function and drug processing: a new study
NCT ID NCT06952634
First seen May 14, 2026 · Last updated May 24, 2026 · Updated 3 times
Summary
This study looked at how the drug ESK001 is processed in people with different levels of liver function. Researchers gave a single dose to 32 volunteers, including healthy people and those with mild, moderate, or severe liver impairment. The goal was to measure drug levels in the blood and check for side effects, helping to understand if liver problems change how the drug works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC IMPAIRMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Alliance for Multispecialty Research
Knoxville, Tennessee, 37920, United States
-
Orange County Research Center
Lake Forest, California, 92630, United States
-
Orlando Clinical Research Center
Orlando, Florida, 32809, United States
-
Panax Clinical Research
Miami Lakes, Florida, 33104, United States
Conditions
Explore the condition pages connected to this study.